Kathryn Holroyd, MD

Dr. Holroyd’s prior research has focused on the neurologic complications of viral infections. She has previously published on the pathophysiology and immunologic response to COVID-19 infection in the central nervous system, and the humoral response to COVID-19 vaccination in patients with multiple sclerosis. She has also studied the epidemiology of neuroimmunologic conditions worldwide including a survey of diagnostic and treatment accessibility across low and middle income countries, and the prevalence of neuromyelitis optica in the United Arab Emirates.

Currently, Dr. Holroyd’s research focuses on better understanding the pathophysiology of cerebrovascular disease in people living with HIV through the use of blood biomarkers, MRI brain imaging, and peripheral imaging of endothelial function. Her work is based in Bangkok, Thailand with an established cohort of people diagnosed and treated during acute HIV infection, providing a unique insight into the effects of HIV on the brain in the earliest days following infection. She has submitted multiple NIH research grants to support this work. Dr. Holroyd also has an interest in educational research, with ongoing work in Zambia evaluating the utility of a flipped classroom approach to neurology education for medical students, funded by an American Academy of Neurology educational research grant.